GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Middle East Pharmaceutical Industries Co (SAU:4016) » Definitions » Scaled Net Operating Assets

Middle East Pharmaceutical Industries Co (SAU:4016) Scaled Net Operating Assets : N/A (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Middle East Pharmaceutical Industries Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Middle East Pharmaceutical Industries Co's operating assets for the quarter that ended in Jun. 2024 was ﷼444.3 Mil. Middle East Pharmaceutical Industries Co's operating liabilities for the quarter that ended in Jun. 2024 was ﷼122.5 Mil. Middle East Pharmaceutical Industries Co's Total Assets for the quarter that ended in Jun. 2023 was ﷼0.0 Mil. Therefore, Middle East Pharmaceutical Industries Co's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was N/A.

Middle East Pharmaceutical Industries Co Scaled Net Operating Assets Historical Data

The historical data trend for Middle East Pharmaceutical Industries Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Middle East Pharmaceutical Industries Co Scaled Net Operating Assets Chart

Middle East Pharmaceutical Industries Co Annual Data
Trend
Scaled Net Operating Assets

Middle East Pharmaceutical Industries Co Semi-Annual Data
Jun23 Jun24
Scaled Net Operating Assets - -

Competitive Comparison of Middle East Pharmaceutical Industries Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Middle East Pharmaceutical Industries Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Middle East Pharmaceutical Industries Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Middle East Pharmaceutical Industries Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Middle East Pharmaceutical Industries Co's Scaled Net Operating Assets falls into.


Middle East Pharmaceutical Industries Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Middle East Pharmaceutical Industries Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in . 20 is calculated as

Scaled Net Operating Assets (SNOA)(A: . 20 )
=(Operating Assets (A: . 20 )-Operating Liabilities (A: . 20 ))/Total Assets (A: . 20 )
=(-)/
=

where

Operating Assets(A: . 20 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
= -
=

Operating Liabilities(A: . 20 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
= - -
=

Middle East Pharmaceutical Industries Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2024 )
=(Operating Assets (Q: Jun. 2024 )-Operating Liabilities (Q: Jun. 2024 ))/Total Assets (Q: Jun. 2023 )
=(444.327-122.466)/0
=N/A

where

Operating Assets(Q: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=465.958 - 21.631
=444.327

Operating Liabilities(Q: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=128.804 - 0 - 6.338
=122.466

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Middle East Pharmaceutical Industries Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Middle East Pharmaceutical Industries Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Middle East Pharmaceutical Industries Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Middle East Pharmaceutical Industries Co (SAU:4016) » Definitions » Scaled Net Operating Assets
Comparable Companies
Traded in Other Exchanges
N/A
Address
8146 King Muhammad V, Sulaimaniyah, P.O. Box 4180, Riyadh, SAU, 11491
Website
Middle East Pharmaceutical Industries Co is a holding company is engaged in manufacturing medicines, medicated and non-medicated creams and gels.

Middle East Pharmaceutical Industries Co Headlines

No Headlines